Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
FDA has approved a test for hepatitis C (HCV) that can deliver results within an hour, setting the stage for same-day test-and-treatment for HCV.News Article updated on 07/10/2024
-
PrEP's 12th Anniversary
"July 16th marks the anniversary of the U.S. Food and Drug Administration’s (FDA) approval of HIV pre-exposure prophylaxis (PrEP)."News Article updated on 07/17/2024 -
Keeping Up-to-Date on Mpox
The nation quickly got the Mpox outbreak of 2022-2023 under control. Some cities did great work in getting people at risk vaccinated. Some, not so good. Diligence is in order.News Article updated on 07/16/2024 -
Funding Opportunity: A System-Level Syndemic Approach to Improve HIV Care and Treatment for People from Racial and Ethnic Minority Groups – DEMONSTRATION SYSTEMS (HRSA-24-107)
This HRSA HIV/AIDS Bureau pre-application webinar is for the funding opportunity, A System-Level Syndemic Approach to Improve HIV Care and Treatment for People from Racial and Ethnic Minority Groups – Demonstration Systems (HRSA-24-107).Resource updated 07/19/2024
-
Funding Opportunity: A System-Level Syndemic Approach to Improve HIV Care and Treatment for People from Racial and Ethnic Minority Groups – EVALUATION AND TA PROVIDER (HRSA-24-108)
This HRSA HIV/AIDS Bureau pre-application webinar is for the funding opportunity, A System-Level Syndemic Approach to Improve HIV Care and Treatment for People from Racial and Ethnic Minority Groups – EVALUATION AND TA PROVIDER (HRSA-24-108).Resource updated 07/19/2024
-
National Youth HIV and AIDS Awareness Day
April 10 is National Youth HIV and AIDS Awareness Day.
Event updated 07/17/2024
-
2023 Part B Administrative Reverse Site Visit 2023
Agenda and presentation slides from the Part B ARSV, hosted by HRSA HAB DSHAP.Resource updated 05/29/2024
-
New Tools and Webinars from the AETC Clinical Training Network
-
National HIV Curriculum
-
Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed
Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication compared to daily oral ART in people who had been unable to maintain viral suppression through an oral daily regimen.News Article updated on 02/28/2024 -
New Guidelines on Use of Statins in HIV Care
Read the new guidelines on use of statins in New Guidelines for Use of Statins by People with HIV to Prevent Cardiovascular Events (HIV.gov blog, 2/29/24).News Article updated on 03/01/2024 -
National Clinician Consultation Center
-
Syphilis Cases Continue to Climb
Syphilis cases continue to climb in the U.S. In April 2023, CDC reported a 32% increase in cases from 2020 to 2021 (133,954 to 176.713 cases). In 2022, cases had jumped yet again, to 203,500.News Article updated on 03/04/2024 -
340B and AIDS Drug Assistance Programs: Getting the Best Price
Information for ADAPS on leveraging discounts and rebates under the 340B program and compliance requirements.Resource updated 05/29/2024
-
Keep Track of CROI 2024: HIV.gov Blogs
CROI 2024 is underway. Keep track via HIV.gov blogs.News Article updated on 03/05/2024 -
HepVu Map on Hep C, Opioids
New data on Hepatitis C and other health indicators are available on HepVu.News Article updated on 03/08/2024 -
CROI 2024 Highlights from HIV.gov
CROI 2024 highlights from HIV.gov:News Article updated on 03/07/2024 -
YGetIt? Program
The YGetIt? Program engaged youth and young adults with HIV in care through three components: a health management mobile application (GET!), Peer Engagement Educator Professionals (PEEPs), and a graphic serial (Tested). Tested received over 200,000 views, and viral suppression rates among YGetIt? participants increased from 79% to 86% over the course of the program.Resource from the RWHAP Best Practices Compilation updated on 03/18/2024
-
National ADAP Formulary Database
NASTAD’s National AIDS Drug Assistance Program (ADAP) Formulary Database provides an online, searchable, publicly available resource detailing state-by-state ADAP coverage of medications, including HIV antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, mental health and substance use treatment medications, and various vaccines and laboratory tests.
Resource updated 03/07/2024
-
INFINI-T
INFINI-T is a program designed to reach young transgender women of color with HIV and retain them in care through peer advocates who provided case management. These peer advocates facilitated social support sessions with the goal of alleviating the negative impacts of psychosocial factors like history of trauma, stigma, and discrimination. Clients were more likely to be virally suppressed and retained in care after 12 months of participating in the intervention.Resource from the RWHAP Best Practices Compilation updated on 07/11/2024